Meet Our Team
Encompassing a wealth of scientific, manufacturing and drug development talent, the MOD3 Pharma team brings together all the experience, skills and knowledge required to support the end-to-end development of innovative OINDPs.
Find out more about our team below, and for details of our executive leadership team, please click here.
Angelo P. Consalvo
DIRECTOR, MANUFACTURING
Angelo offers over three decades of expertise in process development and cGMP manufacturing. He has successfully and repeatedly scaled processes from bench to commercial production. He has played a key role in advancing cGMP manufacturing for solid oral dosage forms and led the design and validation of a state-of-the-art 6,000-sf cGMP facility for high-potency API handling, strengthening MOD3 Pharma’s footprint in the OINDP space.
Previously, Angelo spent two decades at Unigene Laboratories, spearheading the development of scalable manufacturing processes for recombinant peptides and proteins. A prolific innovator, he has authored over 15 peer-reviewed publications and holds 20 U.S. and international patents. Angelo holds a B.S. in Chemistry from SUNY Fredonia.
Andrejs Rasums
DIRECTOR OF QUALITY ASSURANCE
Andrejs Rasums has over 20 years experience in the biopharmaceutical industry with a strong focus on compliance and cGMP regulations. Since joining the company in 2013, he has played a pivotal role in maintaining the Quality System and overseeing GMP documentation, validations, and qualifications for both internal and client-sponsored programs. Previously, he served as Director of Quality Assurance at Unigene Laboratories, where he led quality oversight initiatives. Prior to that, he held leadership positions as Quality Systems Manager and Quality Control Manager, where he established and managed the Quality Control Laboratory.
His career spans supervisory and management roles in both start-ups and established companies within the medical device and diagnostics industries. Mr. Rasums holds a B.A. in Biology from New York University and brings a wealth of expertise to MOD3 Pharma’s commitment to quality excellence.
George Richard Velez
DIRECTOR OF ANALYTICAL RESEARCH AND DEVELOPMENT
George has over three decades experience in the field of analytical chemistry and biopharmaceutical development. With a specialized focus on method development, regulatory compliance, and strategic project management, Mr. Velez has played an instrumental role in advancing drug substances and drug products. His career spans leadership positions at renowned organizations, including Ascend Laboratories, PLIVA, and IVAX Pharmaceuticals, where he led cutting-edge analytical services, facilitated successful technology transfers, and contributed to critical regulatory filings for ANDA and IND submissions. Mr. Velez’s expertise extends to method validation, stability studies, and the meticulous management of analytical laboratories, ensuring full compliance with cGMP standards.
He has made several valuable contributions to the scientific community, with numerous peer-reviewed publications to his name. He holds a Bachelor of Science in Chemistry from Stockton State College and pursued graduate studies in Physical-Analytical Chemistry at the University of Utah.
Raymundo G. Claudio
SENIOR PHARMACEUTICAL
PROCESS ENGINEER II
Ray Claudio offers over two decades experience in the biotech and pharmaceutical industries. Specializing in pharmaceutical CMC, particle engineering, and powder processing, he addresses the complex challenges of orally inhaled and nasal drug products. Ray has pioneered proprietary particle engineering processes that were crucial in expanding the MOD3 Pharma portfolio. With a proven track record in formulation development, process optimization, and scale-up, Ray has played a key role in introducing key technologies to the company’s offerings, including spray drying.
Previously, as Product Development Lead at Unigene Laboratories, he further honed his expertise by taking products from feasibility to late-phase development. His career spans quality control, analytical development, and clinical manufacturing of oral solids dose and respiratory dry powder. Ray holds a B.S. in Biological Sciences from Rutgers University and is the holder of multiple patents, reflecting his ongoing commitment to innovation in pharmaceutical development.
SANA HOSSEINI, PH.D.
PRINCIPAL ENGINEER, CMC
Sana holds a Ph.D. in Mechanical and Nuclear Engineering from Virginia Commonwealth University (VCU). In her seamless transition from academia to industry, she has accumulated extensive experience in pharmaceutical product development, leveraging her academic foundation to drive innovation and solutions in the field. Her expertise is in formulation and process design for complex molecules, with a focus on particle engineering for pulmonary and intranasal dry powder drug products. Prior to joining MOD3 Pharma, Sana worked in product development departments of various leading CDMOs, as a Senior Engineer, and scientist, where she pioneered engineering processes for dry powder nasal vaccines and biotherapeutics and led formulation development for oral solid dosage forms of challenging BCS II molecules.
During her academic tenure, Sana played a pivotal role in various U.S. FDA-funded programs, contributing to the development and commercialization of the VCU-SML Nasal Models—now a cornerstone for biorelevant in vitro nasal spray testing. Through her postdoctoral appointment and graduate research at the VCU Aerosol Research Center of Excellence, she received multiple awards for research distinction. To this day, she remains an active scholar, continuously advancing the field through publications and peer reviews in esteemed pharmaceutical journals.
